Wall Street is positive on Novartis AG (NVS). On average, analysts give NVS a Buy rating. The average price target is $103, which means analysts expect the stock to rise by 28.30% over the next twelve months.
That average ranking earns NVS an Analyst Rating of 19, which is better than 19% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating NVS a Buy today. Find out what this means to you and get the rest of the rankings on NVS!
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What's Happening With Novartis AG Stock Today?
Novartis AG (NVS) stock has fallen -0.63% while the S&P 500 has risen 1.55% as of 3:30 PM on Monday, Nov 29. NVS is lower by -$0.51 from the previous closing price of $80.79 on volume of 2,054,216 shares. Over the past year the S&P 500 has gained 28.83% while NVS is lower by -11.62%. NVS earned $4.34 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 18.51.
Click Here to get the full Stock Report for Novartis AG stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter